 |
Recombinant human IgG1 kappa light chain monoclonal antibody targeting plasma kallikrein |
|---|---|
| Trade Name | |
| Orphan Indication | Hereditary angioedema |
| EU Market Approval | EU |
| EU Designation Date | 2015-10-09 00:00:00 |
| Sponsor | Shire Pharmaceuticals Ireland Limited |
Related Access Program